News - Global, Respiratory and Pulmonary


Popular Filters

Global asthma treatment market to reach $21.6 billion by 2019


The global asthma treatment market is estimated to reach a value of $21.6 billion by 2019, due not only…

GlaxoSmithKlineGlobalMarkets & MarketingPharmaceuticalRelvarRespiratory and Pulmonary

Galapagos and AbbVie enter into cystic fibrosis alliance

Galapagos and AbbVie enter into cystic fibrosis alliance


Belgium-based Galapagos and US drugmaker AbbVie have entered into a global alliance to discover novel…

GlobalPharmaceuticalResearchRespiratory and Pulmonary

Novel LABA/LAMA products will capture greater market share than the LABA/ICS or LAMA drug classes by 2022


The drug market for chronic obstructive pulmonary disease (COPD) therapies will see the emergence of…

AdvairAnoroBoehringer IngelheimGlaxoSmithKlineGlobalMarkets & MarketingPharmaceuticalRelvarRespiratory and PulmonarySpirivaTheravance

Global asthma market to reach 159 million lifetime cases by 2022


Over 300 million people suffer from asthma, which translates to a drug market worth over $15 billion.…

GlaxoSmithKlineGlobalMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySeretideSingulair

New LABA/LAMA drugs set to fracture COPD market


The drug market for chronic obstructive pulmonary disease (COPD) therapies will become more fractured…

AdvairBoehringer IngelheimGlaxoSmithKlineGlobalMarkets & MarketingPfizerPharmaceuticalRespiratory and PulmonarySpiriva

Global asthma and COPD drug market to reach nearly $27 billion in 2017


The global asthma and chronic obstructive pulmonary disease (COPD) market was worth $25.102 billion in…

GlobalMarkets & MarketingPharmaceuticalRespiratory and Pulmonary

COPD market to grow to more than $13.4 billion in 2020


As a result of an expanding aging population, increases in drug treatment and the uptake of premium priced…

Boehringer IngelheimGlobalMarkets & MarketingolodaterolPharmaceuticalRespiratory and Pulmonarytiotropium

New global data on influenza vaccine provision and level of support for immunization policies


The findings of two studies being published this week in peer-reviewed journals look at global vaccination…

GlobalHealthcarePharmaceuticalRespiratory and PulmonaryVaccines

Asthma and COPD drug revenues to reach $43.8 billion in 2015, says Visiongain


Worldwide sales of asthma and chronic obstructive pulmonary disease (COPD) drugs will reach a value of…

GlobalMarkets & MarketingPharmaceuticalRespiratory and Pulmonary

Back to top